Skip to content

Zhejiang Hisun Pharmaceutical Co Ltd Sustainability Reports

The company integrates the research, development, manufacturing, and global distribution of active pharmaceutical ingredients (APIs) and finished dosages. Its therapeutic portfolio includes anti-tumor, cardiovascular, anti-infective, and immunosuppressant medications.

Sector: Manufacturing

Country: China

Exchange: Shanghai Stock Exchange

FIGI: BBG001S8YD76

7 reports from 2021 to 2024